Summary of Significant Accounting Policies (Details Narrative) - USD ($)
|
|
1 Months Ended |
12 Months Ended |
Apr. 16, 2021 |
Dec. 17, 2021 |
Dec. 31, 2021 |
Dec. 31, 2020 |
| Property, Plant and Equipment [Line Items] |
|
|
|
|
|
| Deferred Revenue |
[1],[2] |
|
|
$ 50,500,000
|
|
| [custom:AccountsReceivablesAmounted-0] |
|
|
|
50,640,000
|
4,000
|
| [custom:AccountsReceivablesAmountedGrants-0] |
|
|
|
200,000
|
61,000
|
| Allowance for Doubtful Accounts, Premiums and Other Receivables |
|
|
|
74,000
|
44,000
|
| Money Market Funds, at Carrying Value |
|
|
|
52,300,000
|
28,800,000
|
| Foreign currency translation adjustments, net of tax |
|
|
|
$ 1,544,000
|
$ 2,986,000
|
| Maximum [Member] |
|
|
|
|
|
| Property, Plant and Equipment [Line Items] |
|
|
|
|
|
| Property, Plant and Equipment, Useful Life |
|
|
|
|
10 years
|
| Finite-Lived Intangible Asset, Useful Life |
|
|
|
|
10 years
|
| Minimum [Member] |
|
|
|
|
|
| Property, Plant and Equipment [Line Items] |
|
|
|
|
|
| Property, Plant and Equipment, Useful Life |
|
|
|
3 years
|
|
| Finite-Lived Intangible Asset, Useful Life |
|
|
|
5 years
|
|
| Collaborative Arrangement [Member] |
|
|
|
|
|
| Property, Plant and Equipment [Line Items] |
|
|
|
|
|
| Deferred Revenue |
|
|
|
|
$ 100,000
|
| Collaborative Arrangement [Member] | Maximum [Member] |
|
|
|
|
|
| Property, Plant and Equipment [Line Items] |
|
|
|
|
|
| Deferred Revenue |
|
|
|
$ 800,000
|
|
| Deferred Revenue, Revenue Recognized |
|
|
|
800,000
|
|
| Collaborative Arrangement [Member] | Minimum [Member] |
|
|
|
|
|
| Property, Plant and Equipment [Line Items] |
|
|
|
|
|
| Deferred Revenue |
|
|
|
49,700,000
|
|
| Deferred Revenue, Revenue Recognized |
|
|
|
$ 300,000
|
|
| Immunomic Therapeutics Inc [Member] | Collaborative Arrangement [Member] |
|
|
|
|
|
| Property, Plant and Equipment [Line Items] |
|
|
|
|
|
| Upfront licensing fees |
|
$ 2,000,000.0
|
$ 50,000,000.0
|
|
|
| Immunomic Therapeutics Inc [Member] | Collaborative Arrangement [Member] | Maximum [Member] |
|
|
|
|
|
| Property, Plant and Equipment [Line Items] |
|
|
|
|
|
| Upfront licensing fees |
|
$ 67,000,000.0
|
$ 620,000,000.0
|
|
|
| Royalty percentage |
|
10.00%
|
|
|
|
|
|